Skip to main navigation Skip to search Skip to main content

Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease

Alaa El-Hussuna, Jens Andersen, Thue Bisgaard, Per Jess, Mads Henriksen, Jacob Oehlenschlager, Ole Thorlacius-Ussing, Gunnar Olaison

75 Citations (Scopus)

Abstract

There are concerns that biologic treatments or immunomodulation may negatively influence anastomotic healing. This study investigates the relationship between these treatments and anastomotic complications after surgery for Crohn's disease.
Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume47
Issue number6
Pages (from-to)662-8
Number of pages7
ISSN0036-5521
DOIs
Publication statusPublished - 2012

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anastomosis, Surgical
  • Anastomotic Leak
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Child
  • Colon
  • Crohn Disease
  • Female
  • Glucocorticoids
  • Humans
  • Immunoglobulin Fab Fragments
  • Immunosuppressive Agents
  • Intestine, Small
  • Intraabdominal Infections
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Polyethylene Glycols
  • Postoperative Complications
  • Prednisolone
  • Retrospective Studies
  • Risk Factors
  • Surgical Wound Dehiscence
  • Young Adult

Fingerprint

Dive into the research topics of 'Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease'. Together they form a unique fingerprint.

Cite this